High-grade serous ovarian carcinoma organoids as models of chromosomal instability
M. Vias, L. Morrill Gavarro, C. M. Sauer, D. Sanders, A. M. Piskorz, D.-L. Couturier, S. Ballereau, B. Hernando, J. Hall, F. Correia-Martins, F. Markowetz, G. Macintyre, J. D. Brenton
Abstract
High-grade serous ovarian carcinoma (HGSOC) is the most genomically complex cancer, characterised by ubiquitous TP53 mutation, profound chromosomal instability and heterogeneity. The mutational processes driving chromosomal instability in HGSOC can be distinguished by specific copy number signatures. To develop clinically relevant models of these mutational processes we derived 15 continuous HGSOC patient-derived organoids (PDOs). We carried out detailed bulk transcriptomic, bulk genomic, single cell genomic, and drug sensitivity characterisation of the organoids. We show that PDOs comprise communities of different clonal populations and represent models of different causes of chromosomal instability including homologous recombination deficiency, chromothripsis, tandem-duplicator phenotype and whole genome duplication. We also show that these PDOs can be used as exploratory tools to study transcriptional effects of copy number alterations as well as compound-sensitivity tests. In summary, HGSOC PDO cultures provide a genomic tool for studies of specific mutational processes and precision therapeutics.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TP53 loss initiates chromosomal instability in high-grade serous ovarian cancer
D. Bronder, D. Wangsa, … S. S. Taylor·Disease Models & MechanismsPeer-reviewed·Nov 30, 2021
- Most commonly mutated genes in High Grade Serous Ovarian Carcinoma are nonessential for ovarian surface epithelial stem cell transformation
R. J. Yamulla, S. Nalubola, … J. C. Schimenti·bioRxiv·Jan 27, 2020
- The genomic trajectory of ovarian high grade serous carcinoma is determined in STIC lesions
Zhao Cheng, Darren P. Ennis, … Iain A. McNeish·The Journal of PathologyPeer-reviewed·Jul 2, 2024
- Combinatorial organoid mutagenesis screen reveals gene constellations driving malignant transformation, pathology and chemosensitivity in high-grade serous ovarian carcinoma
Daryl J. Phuong, Coulter Q. Ralston, … John C. Schimenti·bioRxiv·Mar 10, 2025
- Both Fallopian Tube and Ovarian Surface Epithelium Can Act as Cell-of-Origin for High Grade Serous Ovarian Carcinoma
B. G. Neel, S. Zhang, … D. A. Levine·bioRxiv·Nov 29, 2018
- A platform for efficient establishment, expansion and drug response profiling of high-grade serous ovarian cancer organoids
W. Senkowski, L. Gall-Mas, … K. Wennerberg·bioRxiv·Apr 21, 2022